Abstract
This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health (“mHealth”) technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self‐management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.
Highlights
Triage tests for identifying atrial fibrillation in primary care: A diagnostic accuracy study comparing single-lead ECG and modified Blood pressure (BP) monitors
Atrial fibrillation identification depends on factors having to do with the arrhythmia itself, that is the combination of atrial fibrillation (AF) prevalence and density (Charitos et al, 2012), and factors associated with detection such as the frequency and duration of monitoring and diagnostic test performance (Ramkumar et al, 2018)
The results showed reduction in the combined endpoint of percentage of days lost due to unplanned hospitalization and all-cause mortality
Summary
Digital health is an umbrella term to describe the use of digital information, data, and communication technologies to collect, share, and analyze health information in order to improve patient health, education, and healthcare delivery (https://www.fcc.gov/general/five-questions-youcan-ask-your-doctor-about-digital-health#ab; Turakhia et al, 2016) This concept encompasses telehealth, electronic health records, implantable device monitoring, wearable sensor data, analytics and artificial intelligence (AI), behavioral health, and personalized medicine. Mobile health—or “mHealth” is a component of digital health, defined by the World Health Organization—as “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs), and other wireless devices” (https://www.who.int/goe/publications/goe_mhealth_web.pdf; https:// apps.who.int/gb/ebwha/pdf_files/WHA71/A71_20-en.pdf?ua=1) (World Health Organization, 2011; World Health Organization, 2018) Utilization of these devices has proliferated among health-conscious consumers in recent years and is likely to continue rapid expansion and integration into more formalized medical settings. All stakeholders need to be aware of the logistical chain (so that everyone knows what to expect) and responsibilities clearly defined
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
